DEFINITIVE PROXY STATEMENT

Company

Citius Pharmaceuticals, Inc.

Filed

December 20, 2019

Period of Report

February 10, 2020

Accession Number

0001213900-19-026703

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →